MedTrace Logo

Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)

NCT04637672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1273

Last updated 2024-05-22

No results posted yet for this study

Summary

Myositis are rare diseases for which the development of a cohort associated with a bank of biological samples (biobank) will allow for the conduct of researches to better delineate the underlying pathophysiology and find cures. This prospective cohort of patients with myositis will allow for identification of factors favouring the occurrence of myositis, whether they are constitutional (genetic) or acquired (environmental or drug). Different subgroups of myositis used for prognostication will be identified based on clinico-demographical variables, the nature of the organs involved beyond peripheral muscles (cardiac, diaphragm) and biomarkers abnormalities.

Conditions

  • Inflammatory Myositis
  • Idiopathic Inflammatory Myositis
  • Drug-induced Inflammatory Myositis

Sponsors & Collaborators

  • Groupe Hospitalier Pitie-Salpetriere

    lead OTHER

Principal Investigators

  • Olivier Benveniste, PU PH · Groupe Hospitalier Pitie-Salpetriere

  • Yves Allenbach · Groupe Hospitalier Pitie-Salpetriere

  • Joe Elie SALEM · Groupe Hospitalier Pitie-Salpetriere

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-19
Primary Completion
2023-12-14
Completion
2023-12-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04637672 on ClinicalTrials.gov